Primary genito-urinary tuberculosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:645874A18.1
Who is this for?
Show terms as
1FDA treatments6Active trials69Specialists8Treatment centers

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Urogenital tuberculosis
Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

Yale University — NA

TrialRECRUITING
Dec 2025Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients

Sohag University

TrialNOT YET RECRUITING
Aug 2025Questioning the Epidemiology of Asymptomatic TB

Barcelona Institute for Global Health

TrialRECRUITING
Oct 2024Effects of Tuberculosis Infection on Development and Function of the Placenta

Lund University

TrialRECRUITING
Aug 2024Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

University of California, San Francisco — NA

TrialRECRUITING
Mar 2024South Africa Smoking Cessation and Engagement in HIV/TB Care Care

Massachusetts General Hospital — NA

TrialRECRUITING
Jan 2024Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV

The Aurum Institute NPC — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING
Sep 2023Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Johns Hopkins University — NA

TrialRECRUITING
Sep 2023Characteristics and Outcomes of TB and HIV Co-infections

Assiut University

TrialRECRUITING
Aug 2023A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

Stellah Mpagama — PHASE3

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Paser Granules

Aminosalicylic acid· Jacobus Pharmaceutical CompanyOrphan Drug

Treatment of tuberculosis

View Details →

Clinical Trials

6 recruitingView all trials with filters →
Phase 31 trial
A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis
Phase 3
Actively Recruiting
· Sites: Moshi, Kilimanjaro · Age: 18–65 yrs
View on ClinicalTrials.gov ↗I'm interested →
Phase 41 trial
Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients
Phase 4
Active
PI: Gavin Churchyard (Aurum Institute) · Sites: Pune, Maharashtra; Jakarta, Jaya +2 more · Age: 13–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
N/A3 trials
South Africa Smoking Cessation and Engagement in HIV/TB Care Care
N/A
Actively Recruiting
PI: Amelia Stanton, PhD (Boston University) · Sites: Rondebosch · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
N/A
Actively Recruiting
PI: J. Lucian Davis, MD, MAS (Yale University) · Sites: Kampala · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
N/A
Actively Recruiting
· Sites: Mbabane; Maseru +3 more
View on ClinicalTrials.gov ↗I'm interested →
Other1 trial
Questioning the Epidemiology of Asymptomatic TB
Actively Recruiting
· Sites: Manhiça, Maputo Province · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →

Specialists

Showing 25 of 69View all specialists →
AM
Awewura Kwara, MD
GAINESVILLE, FL
Specialist
PI on 5 active trials1 Primary genito-urinary tuberculosis publication
JM
Joseph A Kovacs, M.D.
Specialist
PI on 6 active trials
JM
J. Lucian Davis, MD
Specialist
PI on 3 active trials
WM
Walter K Kraft, MD
PHILADELPHIA, PA
Specialist
PI on 4 active trials1 Primary genito-urinary tuberculosis publication
AP
Amelia Stanton, PhD
Boston, Massachusetts
Specialist

Rare Disease Specialist

PI on 2 active trials
GC
Gavin Churchyard
Specialist
PI on 2 active trials
AA
Anchalee Avihingsanon
Specialist
PI on 3 active trials
CH
Christopher Hoffmann
Specialist
PI on 3 active trials
MR
Morten Ruhwald
Specialist
PI on 2 active trials
FC
Frank Cobelens
Specialist
PI on 2 active trials
WM
Weerawat Manosuthi
Specialist
PI on 2 active trials
JH
Judith A Hahn
Specialist
PI on 2 active trials
AG
Amita Gupta
Specialist
PI on 1 active trial
KS
Kimberly Scarsi
Specialist
PI on 1 active trial
SS
Soumya Swaminathan
Specialist
PI on 3 active trials
FB
François-Xavier Blanc
Specialist
PI on 1 active trial
MR
Mary Jane Rotheram-Borus
Specialist
PI on 2 active trials
WB
William Burman
DENVER, CO
Specialist
PI on 1 active trial
DB
Debra Benator
WASHINGTON, DC
Specialist
PI on 1 active trial
CW
Christopher Whalen
Specialist
PI on 1 active trial
JM
Jun Chen, M.D
Specialist
PI on 1 active trial
EA
Eleni Aklillu
Specialist
PI on 1 active trial
OF
Onyema Ogbuagu, MBBCh, FACP
Specialist
PI on 1 active trial
MW
Marc Weiner
Specialist
PI on 1 active trial
CM
Cinta Moraleda
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Primary genito-urinary tuberculosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Primary genito-urinary tuberculosisForum →

No community posts yet. Be the first to share your experience with Primary genito-urinary tuberculosis.

Start the conversation →

Latest news about Primary genito-urinary tuberculosis

Disease timeline:

New recruiting trial: Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

New recruiting trial: Characteristics and Outcomes of TB and HIV Co-infections

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

New recruiting trial: An Adaptive Randomized Controlled Trial

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

New recruiting trial: South Africa Smoking Cessation and Engagement in HIV/TB Care Care

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

New recruiting trial: A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

New recruiting trial: Effects of Tuberculosis Infection on Development and Function of the Placenta

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

New recruiting trial: Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

New recruiting trial: Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

New recruiting trial: Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

New recruiting trial: Questioning the Epidemiology of Asymptomatic TB

A new clinical trial is recruiting patients for Primary genito-urinary tuberculosis

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Primary genito-urinary tuberculosis

Are there clinical trials for Primary genito-urinary tuberculosis?

Yes — 6 recruiting clinical trials are currently listed for Primary genito-urinary tuberculosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Primary genito-urinary tuberculosis?

25 specialists and care centers treating Primary genito-urinary tuberculosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Primary genito-urinary tuberculosis?

1 patient support program are currently tracked on UniteRare for Primary genito-urinary tuberculosis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.